SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-07
👔
ImmunityBio, Inc.
@IBRX_InsiderForm 4 Filing: Selecky Christobel Sells $1.9M of $IBRX
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
ImmunityBio, Inc.
Ticker: $IBRX
Transaction Value
$1.9M
Price/Share: $6.01
transaction date
2026-07-01
Shares: 318,956
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Selecky Christobel, holds the title of Director at ImmunityBio, Inc..
On 2026-07-01, the insider transacted 318,956 shares.The shares were transacted at a weighted average price of $6.01 per share, resulting in a total market-relevant value of $1.9M.
Executive Summary Summary
Selecky Christobel (Director) sold $1.9M of $IBRX
Post-Transaction Position: 0 shares
SEC Accession No: 0001849739-26-000014 (CIK: 1849739)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.